Historical record - last NADAC publication: 9/20/2023
Product Information
DOXEPIN HCL 3 MG TABLET is a generic product labeled by Currax Pharmaceuticals LLC, priced at $5.4953 per EA under NDC 44183010330. Its NADAC has been published 180 times since Apr 22, 2020.
The High Outlier badge above means this manufacturer's average price in the doxepin hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
3 mg/1
Manufacturer
Currax Pharmaceuticals LLCNDC
44183010330
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
9/20/2023
Active Ingredients
DOXEPIN HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA022036On Market Since
8/1/2010
Pharmacological Classes
Price Statistics
The NADAC for DOXEPIN HCL 3 MG TABLET has been published 180 times since Apr 22, 2020, and over the history we have for it it has declined 46.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.4953 per EA |
|---|---|
| All-time high | $10.8829 (Oct 14, 2020) |
| All-time low | $5.4953 (Sep 20, 2023) |
| Median price | $8.4787 |
| Average price | $8.6693 |
| Largest weekly change | -32.6% (Sep 20, 2023) |
| Weeks tracked | 180 |
| Tracking since | Apr 22, 2020 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 75% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DOXEPIN HCL 3 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN HCL 3 MG TABLET, manufactured by Currax Pharmaceuticals LLC, is $5.4953 per EA (NDC 44183010330), effective Sep 27, 2023.
How has the price of DOXEPIN HCL 3 MG TABLET changed over time?
Over the history we have for it, the NADAC for DOXEPIN HCL 3 MG TABLET has declined 46.2%. It has been tracked across 180 weekly CMS publications since Apr 22, 2020.
What are the highest and lowest recorded NADAC prices for DOXEPIN HCL 3 MG TABLET?
Since Apr 22, 2020, the NADAC for DOXEPIN HCL 3 MG TABLET has ranged from a low of $5.4953 (Sep 20, 2023) to a high of $10.8829 (Oct 14, 2020), with a median of $8.4787 per EA.
Are there cheaper alternatives to DOXEPIN HCL 3 MG TABLET?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, DOXEPIN HCL 3 MG TABLET, is $1.3614 per EA — about 75% below DOXEPIN HCL 3 MG TABLET.
Who manufactures DOXEPIN HCL 3 MG TABLET?
DOXEPIN HCL 3 MG TABLET (NDC 44183010330) is labeled by Currax Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification